QI
CRL icon

Qtron Investments’s Charles River Laboratories CRL Stock Holding History

Qtron Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
+2,017
New +$359K 0.06% 343
2025
Q1 		– Sell
-2,938
Closed -$542K – 391
2024
Q4 		$542K Buy
+2,938
New +$566K 0.08% 307
2024
Q3 		– Sell
-4,588
Closed -$948K – 426
2024
Q2 		$948K Buy
4,588
+1,042
+29% +$236K 0.14% 176
2024
Q1 		$961K Buy
3,546
+1,397
+65% +$334K 0.14% 194
2023
Q4 		$508K Buy
2,149
+596
+38% +$117K 0.08% 323
2023
Q3 		$304K Buy
+1,553
New +$319K 0.06% 359
2023
Q2 		– Sell
-1,625
Closed -$328K – 412
2023
Q1 		$328K Buy
+1,625
New +$368K 0.07% 342
2021
Q4 		– Sell
-1,157
Closed -$477K – 335
2021
Q3 		$477K Buy
1,157
+149
+15% +$61.9K 0.13% 221
2021
Q2 		$373K Sell
1,008
-185
-16% -$61.8K 0.09% 251
2021
Q1 		$346K Buy
+1,193
New +$332K 0.1% 251

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Qtron Investments's CRL Position: Q2 2026 in Review

Qtron Investments opened a new position in Charles River Laboratories (CRL) in Q2 2026: 2,017 shares worth $457K. The stake represents 0.06% of the portfolio and ranks #343 among its holdings. This is a return to the name: Qtron Investments previously reported a position in CRL as recently as Q4 2024.

Qtron Investments first reported a position in CRL in Q1 2021 and has held it in 10 quarters since. The position peaked at $961K in Q1 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Qtron Investments held 2,017 shares of Charles River Laboratories worth $457K as of Q2 2026.
  • Charles River Laboratories was a new Qtron Investments position in Q2 2026.
  • Charles River Laboratories made up 0.06% of Qtron Investments's portfolio in Q2 2026, its #343 holding.
  • Qtron Investments first reported a position in Charles River Laboratories in Q1 2021 and has held it in 10 quarters since.
  • Qtron Investments's Charles River Laboratories position peaked at $961K in Q1 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.